文献速递神经免疫

APRIL通过星形胶质细胞抗炎反应在多发性硬化中发挥保护作用

A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.
PubMed 文献 · Ann Neurol · 2019-02-04

该研究探讨了APRIL/BAFF轴在多发性硬化中枢神经系统中的作用。在实验性自身免疫性脑炎小鼠模型中,APRIL缺失导致疾病加重;多发性硬化病灶中巨噬细胞分泌的APRIL靶向反应性星形胶质细胞,促使其产生IL-10抑制T细胞增殖和致病性细胞因子分泌。重组APRIL给药可减轻EAE症状,且该保护作用不与BAFF共享。

要点

  • APRIL缺失加重EAE,提示其在中枢神经系统具有保护作用
  • 多发性硬化病灶中巨噬细胞分泌的APRIL特异性靶向星形胶质细胞
  • 星形胶质细胞响应APRIL产生IL-10抑制T细胞增殖和致病性细胞因子分泌

核心结论

  • APRIL介导多发性硬化病灶中星形胶质细胞的抗炎反应,该保护活性不与BAFF共享。

研究设计与样本

  • 研究采用免疫组化分析多发性硬化病灶中APRIL表达,在实验性自身免疫性脑炎小鼠模型中评估APRIL体内作用,并用人和小鼠星形胶质细胞进行体外功能研究。

主要发现

  • APRIL在EAE病灶中表达,其缺失导致疾病最重。
  • 多发性硬化患者病灶在巨噬细胞浸润时也显示APRIL表达,巨噬细胞分泌的APRIL特异性靶向星形胶质细胞。
  • 反应性星形胶质细胞上调硫酸软骨素蛋白聚糖(有时携带E型硫酸软骨素糖基)结合APRIL,解释了这种选择性。
  • 星形胶质细胞响应APRIL产生足够量的IL-10,抑制抗原特异性T细胞增殖和致病性细胞因子分泌。
  • 疾病发生前脊髓内递送重组APRIL可短暂减轻EAE症状,反复静脉注射重组APRIL在疾病发生前甚至发生时也有作用。

临床怎么用

  • APRIL/BAFF联合阻断在多发性硬化患者中可能导致中枢神经系统炎症加重,提示治疗策略需考虑APRIL的保护作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The two related tumor necrosis factor members a proliferation-inducing ligand (APRIL) and B-cell activation factor (BAFF) are currently targeted in autoimmune diseases as B-cell regulators. In multiple sclerosis (MS), combined APRIL/BAFF blockade led to unexpected exacerbated inflammation in the central nervous system (CNS) of patients. Here, we investigate the role of the APRIL/BAFF axis in the CNS. METHODS: APRIL expression was analyzed in MS lesions by immunohistochemistry. The in vivo role of APRIL was assessed in the murine MS model, experimental autoimmune encephalitis (EAE). Functional in vitro studies were performed with human and mouse astrocytes. RESULTS: APRIL was expressed in lesions from EAE. In its absence, the disease was worst. Lesions from MS patients also showed APRIL expression upon infiltration of macrophages. Notably, all the APRIL secreted by these macrophages specifically targeted astrocytes. The upregulation of chondroitin sulfate proteoglycan, sometimes bearing chondroitin sulfate of type E sugar moieties, binding APRIL, in reactive astrocytes explained the latter selectivity. Astrocytes responded to APRIL by producing a sufficient amount of IL-10 to dampen antigen-specific T-cell proliferation and pathogenic cytokine secretion. Finally, an intraspinal delivery of recombinant APRIL before disease onset, shortly reduced EAE symptoms. Repeated intravenous injections of recombinant APRIL before and even at disease onset also had an effect. INTERPRETATION: Our data show that APRIL mediates an anti-inflammatory response from astrocytes in MS lesions. This protective activity is not shared with BAFF. ANN NEUROL 2019;85:406-420.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Baert L, Benkhoucha M, Popa N, et al. A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis. Ann Neurol. 2019. PMID: 30635946. doi:10.1002/ana.25415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。